Waters Corp. (WAT), Tuesday announced that its shareholders have approved the issuance of Waters common stock to shareholders of Becton, Dickinson and Company (BDX) as part of the proposed combination of the latter's Biosciences & Diagnostic Solutions business with the company.
At the company's Special Meeting of Shareholders, the proposal received favorable votes from approximately 99 percent of shares present in person or by proxy.
With this approval, the company is planning to close the transaction on February 9, 2026.
"We appreciate the continued support of our shareholders as we move closer to completing this transaction," said CEO Udit Batra. "We look forward to creating meaningful value for patients, customers, employees, and shareholders alike."
Currently, WAT is trading at $390.54, down 0.09 percent, and BDX is trading at $203.36, down 0.02 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.